Aijaz Ahmed

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

Zobair M. Younossi, Maria Stepanova, Janus P. Ong et al. · Clinical Gastroenterology and Hepatology · 2018 · 795 citations · Full text

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

Robert J. Wong, Ramsey Cheung, Aijaz Ahmed · Hepatology · 2013 · 713 citations

Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States

Zobair M. Younossi, Maria Stepanova, Janus P. Ong et al. · Clinical Gastroenterology and Hepatology · 2020 · 535 citations

Hepatology, Nonalcoholic Fatty Liver Disease, Solid Organ Transplantation +10

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Donghee Kim, Peter Konyn, Keeryth K. Sandhu et al. · Journal of Hepatology · 2021 · 404 citations

Metabolic Disorder, Fatty Liver Disease, United States +17